ATLANTA--(BUSINESS WIRE)--Mirion (“we” or the “company”) (NYSE: MIR), a global provider of radiation detection, measurement, analysis, and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced results for the fourth quarter and full year ended December 31, 2024. “We are pleased to report record 2024 performance, with good momentum continuing into 2025,” commented Mirion’s Chief Executive Officer Thomas Logan. “Both fourth quarter and full year performa...
Read the full news release here
